The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Read more about BAP
Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology
A few years ago on the Journal of Psychopharmacology I published an editorial on the need for a new nomenclature in
psychopharmacology [Nutt DJ. (2009) Beyond psychoanaleptics – can we improve antidepressant drug nomenclature?
J Psychopharmacol. 23(4):343-5. Erratum in: J Psychopharmacol. 23(7):861].
This sparked interest from the ECNP who set up a working group with several other international psychopharmacology
organisations e.g. ACNP CINP, and after 5 years of regular meetings a new nomenclature has been develop and posted as a
free educational App.
The next stage is to begin the challenging process of using the new nomenclature in scientific journals and the
Journal of Psychopharmacology is one of about 10 who have agreed to try to do this. The details are in an editorial
in the next edition of the Journal.
So when you write your papers for Journal of Psychopharmacology or Therapeutic Advances in Psychopharmacology please try to
use the attached glossary to explain what drugs you use are and how they work.
Fundamentals of Clinical Psychopharmacology Fourth Edition Out Now
The new edition of the BAP book, Fundamentals of Clinical Psychopharmacology, published in August 2015, is available for purchase here for £20 (RRP £29.99), including postage and packaging.
Fundamentals of Clinical Psychopharmacology provides up-to-date, evidence-based and unbiased information about psychopharmacology. It spans the range of the discipline, from mode of action and side effects of drugs to meta-analyses of clinical trials. It is anchored to practice guidelines produced by the UK National Institute for Health and Care Excellence (NICE) and the British Association for Psychopharmacology (BAP). Care has been taken to provide an international perspective that makes it equally useful to practitioners in the US and other countries. Read more on the publishers website.
Buy the book
The Ten Secrets of Success in Science by Professor Trevor Robbins
The BAP takes supporting the next generation of clinical and preclinical scientists seriously. We do this in a number of ways, including offering discounted trainee membership, support to attend our meetings, training in clinical and non-clinical psychopharmacology, and generous prizes and bursaries to recognise the work of trainees and support them to attend our meetings and other conferences.
We also run a dedicated Trainees' Workshop at our annual meeting to help students and early career researchers develop their careers. Topics have included how to get started in research, how to combine research with family life, how to develop a career in clinical and/or preclinical research and working in industry.
This year in Bristol the workshop included an interactive discussion on the secrets of success in science from Professor Trevor Robbins. Professor Robbins is arguably one of the top ten neuroscientists in the World and has had a major impact on the field. He has also supervised and mentored over 80 PhD and post-doctoral researchers, many of whom have gone on to head research teams in their own right.
You can hear Professor Robbins summarising his top ten secrets for success based on the workshop at this year's summer meeting in the video (above). There are some interesting surprises and there was much more that came out at the workshop!
BAP will run another Trainees’ Workshop at the next summer meeting in Brighton, 17-20 July 2016.
BAP endorses the Fact Sheet on Ketamine Scheduling
Fact Sheet on Ketamine Scheduling (updated 27 Feb 2015)
Extended Fact Sheet on Ketamine Scheduling
Members of CND
International Federation of Red Cross and Red Crescent (IFRC) position paper
Schedule II and IV requirements
Essential veterinary use of ketamine
Read Professor David Nutt's article on the ketamine ban
Update 24 February – in response to a letter from BAP, the Chief Medical Officer, Professor Dame Sally Davies, replies “I would like to assure you that the UK Government supports the continued medical and scientific use of ketamine for the reasons that you have set out. The UK Government will make this point in international fora as appropriate, and will not support its scheduling under the international drug conventions.”
Update 27 February – the final version of the fact sheet and additional advocacy documents are now available to download (above).
SET (Science, Engineering and Technology) for Britain
Nisha presented her biological research to a range of politicians and a panel of expert judges at Parliament.
7th March 2016
What every dictator knows: young men are natural fanatics
Joe wrote an essay for Aeon on the role of testosterone in the making of a fanatic
1st February 2016
University of Oxford Video Series
Phil talks about his interest in psychopharmacology in order to inspire a new generation.
27th January 2016
See more Members' Activities